Prevalence of colistin resistance in clinical isolates of Enterobacteriaceae: A four-year cross-sectional study

Journal of Infection

Volumn 75, Issue 6, 2017, Pages 493-498

  Prim, Núria ^a,b   Turbau, Miquel ^a,c   Rivera, Alba ^a   Rodríguez Navarro, Judith ^a   Coll, Pere ^a,c   Mirelis, Beatriz ^a,c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Laboratori de Referencia de Catalunya   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Colistin; Enterobacteriaceae; mcr 1; mcr 2; Resistance

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CLINICAL FEATURE; COMMUNITY ACQUIRED INFECTION; CONCURRENT INFECTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFUSION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; GENE AMPLIFICATION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MCR 1 GENE; MCR 2 GENE; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; ANALYSIS OF VARIANCE; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; RETROSPECTIVE STUDY; SPAIN; TERTIARY CARE CENTER; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CHILD; COLISTIN; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SPAIN; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 85031324294     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2017.09.008     Document Type: Article

References (30)

1. European Medicines Agency, Updated advice on the use of colistin products in animals within the European Union: development of resistance and possible impact on human and animal health. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211080.pdf, 2016. (Accessed 16 August 2016)
2. Falagas, M.E., Kasiakou, S.K., Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 40 (2005), 1333–1341.
3. Schwarz, S., Johnson, A.P., Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother 71 (2016), 2066–2070.
4. Wertheim, H., Van Nguyen, K., Hara, G.L., Gelband, H., Laxminarayan, R., Mouton, J., et al. Global survey of polymyxin use: a call for international guidelines. J Glob Antimicrob Resist 1 (2013), 131–134.
5. Olaitan, A.O., Morand, S., Rolain, J.M., Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol, 5, 2014, 643.
6. Gales, A.C., Jones, R.N., Sader, H.S., Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004). Clin Microbiol Infect 12 (2006), 315–321.
7. Gales, A.C., Jones, R.N., Sader, H.S., Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY antimicrobial surveillance program (2006-09). J Antimicrob Chemother 66 (2011), 2070–2074.
8. Castanheira, M., Griffin, M.A., Deshpande, L.M., Mendes, R.E., Jones, R.N., Flamm, R.K., Detection of mcr-1 among Escherichia coli clinical isolates collected worldwide as part of the SENTRY antimicrobial surveillance program in 2014 and 2015. Antimicrob Agents Chemother 60 (2016), 5623–5624.
9. Bradford, P.A., Kazmierczak, K.M., Biedenbach, D.J., Wise, M.G., Hackel, M., Sahm, D.F., Correlation of β-Lactamase production and colistin resistance among Enterobacteriaceae isolates from a global surveillance program. Antimicrob Agents Chemother 60 (2015), 1385–1392.
10. Matthaiou, D.K., Michalopoulos, A., Rafailidis, P.I., Karageorgopoulos, D.E., Papaioannou, V., Ntani, G., et al. Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: a matched case-control study. Crit Care Med 36 (2008), 807–811.
11. Kontopidou, F., Plachouras, D., Papadomichelakis, E., Koukos, G., Galani, I., Poulakou, G., et al. Colonization and infection by colistin-resistant gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infec 17 (2011), E9–11.
12. Liu, Y.Y., Wang, Y., Walsh, T.R., Yi, L.X., Zhang, R., Spencer, J., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16 (2016), 161–168.
13. Prim, N., Rivera, A., Rodríguez-Navarro, J., Español, M., Turbau, M., Coll, P., et al. Detection of mcr-1 colistin resistance gene in polyclonal Escherichia coli isolates in Barcelona, Spain, 2012 to 2015. Euro Surveill, 21, 2016 PII: 30183.
14. Wang, Y., Tian, G.B., Zhang, R., Shen, Y., Tyrrell, J.M., Huang, X., et al. Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study. Lancet Infect Dis 17 (2017), 390–399.
15. Quan, J., Li, X., Chen, Y., Jiang, Y., Zhou, Z., Zhang, H., et al. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Lancet Infect Dis 17 (2017), 400–410.
16. Xavier, B.B., Lammens, C., Ruhal, R., Kumar-Singh, S., Butaye, P., Goossens, H., et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill, 21, 2016 PII: 30280.
17. European Centre for Disease Prevention and Control, Antimicrobial resistance surveillance in Europe 2013. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net); Available from: https://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf, 2014. (Accessed 6 September 2016)
18. CLSI, Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA, 2012.
19. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18 (2012), 268–281.
20. European Committee on Antimicrobial Susceptibility Testing, Breakpoint tables for interpretation of MICs and zone diameters version 6.0. Available from: http://www.eucast.org, 2016. (Accessed 6 September 2016)
21. Cardoso, T., Almeida, M., Carratalà, J., Aragão, I., Costa-Pereira, A., Sarmento, A.E., et al. Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review. BMC Infect Dis, 15, 2015, 565.
22. Prim, N., Rivera, A., Español, M., Mirelis, B., Coll, P., In vivo adaptive resistance to colistin in Escherichia coli isolates. Clin Infect Dis 61 (2015), 1628–1629.
23. Olaitan, A.O., Morand, S., Rolain, J.M., Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance. Int J Antimicrob Agents 47 (2016), 1–3.
24. Lo-Ten-Foe, J.R., de Smet, A.M., Diederen, B.M., Kluytmans, J.A., van Keulen, P.H., Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 51 (2007), 3726–3730.
25. Guérin, F., Isnard, C., Sinel, C., Morand, P., Dhalluin, A., Cattoir, V., et al. Cluster-dependent colistin hetero-resistance in Enterobacter cloacae complex. J Antimicrob Chemother 71 (2016), 3058–3061.
26. Napier, B.A., Band, V., Burd, E.M., Weiss, D.S., Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob Agents Chemother 58 (2014), 5594–5597.
27. Liassine, N., Assouvie, L., Descombes, M.C., Tendon, V.D., Kieffer, N., Poirel, L., et al. Very low prevalence of MCR-1/MCR-2 plasmid-mediated colistin resistance in urinary tract Enterobacteriaceae in Switzerland. Int J Infect Dis 51 (2016), 4–5.
28. Kawanishi, M., Abo, H., Ozawa, M., Uchiyama, M., Shirakawa, T., Suzuki, S., et al. Prevalence of colistin resistance gene mcr-1 and absence of mcr-2 in Escherichia coli isolated from healthy food-producing animals in Japan. Antimicrob Agents Chemother, 61, 2017 e02057–16.
29. Woolhouse, M.E., Ward, M.J., Sources of antimicrobial resistance. Science 341 (2013), 1460–1461.
30. Rawson, T.M., Moore, L.S., Hatcher, J.C., Donaldson, H., Holmes, A.H., Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination?. Lancet Infect Dis 16 (2016), 149–150.